Visual grasping in frontotemporal dementia and parkinsonism linked to chromosome 17 (microtubule‐associated with protein tau): A comparison of N‐Isopropyl‐p‐[123I]‐iodoamphetamine brain perfusion single photon emission computed tomography analysis with progressive supranuclear palsy
暂无分享,去创建一个
N. Hattori | K. Yokoyama | K. Ogaki | Y. Motoi | A. Nakanishi | M. Takanashi | Yuanzhe Li | H. Tomiyama | N. Shimizu
[1] K. Kok,et al. Characteristics of dystonia in the 18p deletion syndrome, including a new case , 2009, Clinical Neurology and Neurosurgery.
[2] M. Onofrj,et al. Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment. , 2009, Parkinsonism & related disorders.
[3] J. Winkler,et al. Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegia , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[4] R. Bhidayasiri,et al. Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy , 2009, Movement disorders : official journal of the Movement Disorder Society.
[5] A. Durr,et al. SPG15 is the second most common cause of hereditary spastic paraplegia with thin corpus callosum , 2009, Neurology.
[6] L. Barea,et al. Dystonia, autoimmune disease and cerebral white matter abnormalities in a patient with 18p deletion. , 2009, Arquivos de neuro-psiquiatria.
[7] R. Sakakibara,et al. Levodopa might affect metaiodobenzylguanidine myocardial accumulation , 2008, Movement disorders : official journal of the Movement Disorder Society.
[8] O. Suchowersky,et al. Neuropathy as a potential complication of levodopa use in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[9] A. Durr,et al. Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome. , 2008, American journal of human genetics.
[10] B. Boeve,et al. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). , 2008, Archives of neurology.
[11] N. Elleuch,et al. Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15, and further genetic heterogeneity. , 2008, Archives of neurology.
[12] L. Lopiano,et al. Duodenal levodopa infusion for advanced Parkinson's disease: 12‐month treatment outcome , 2007, Movement disorders : official journal of the Movement Disorder Society.
[13] S. Yamashina,et al. Neuronal imaging using SPECT , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[14] G. Zeevalk,et al. Acute neurotoxic effects of mancozeb and maneb in mesencephalic neuronal cultures are associated with mitochondrial dysfunction. , 2006, Neurotoxicology.
[15] R. Grünewald,et al. Unbalanced whole arm translocation resulting in loss of 18p in dystonia , 2006, Movement disorders : official journal of the Movement Disorder Society.
[16] S. Yamaguchi,et al. Effects of aging on regional cerebral blood flow assessed by using technetium Tc 99m hexamethylpropyleneamine oxime single-photon emission tomography with 3D stereotactic surface projection analysis. , 2005, AJNR. American journal of neuroradiology.
[17] M. Simpson,et al. Complicated Hereditary Spastic Paraplegia with Thin Corpus Callosum (HSP‐TCC) and Childhood Onset , 2005, Neuropediatrics.
[18] W. Kuhn,et al. Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration. , 2004, Archives of neurology.
[19] A. Di Rocco,et al. Effect of l-dopa on plasma homocysteine in PD patients: Relationship to B-vitamin status , 2004, Neurology.
[20] John E Richards,et al. Cortical sources of event-related potentials in the prosaccade and antisaccade task. , 2003, Psychophysiology.
[21] B. Ghetti,et al. Clinical and genetic studies of families with the tau N279K mutation (FTDP-17) , 2002, Neurology.
[22] A. Lang,et al. A novel locus for inherited myoclonus-dystonia on 18p11 , 2002, Neurology.
[23] H. Schaff,et al. Cardiac phaeochromocytoma presenting with severe hypertension and chest pain , 2001, Clinical endocrinology.
[24] M. Brin,et al. Genetic analysis of three patients with an 18p− syndrome and dystonia , 1999, Neurology.
[25] F. Tezzon,et al. Dystonia in a patient with deletion of 18p , 1998, The Italian Journal of Neurological Sciences.
[26] R. Benecke,et al. Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution. , 1996, Human molecular genetics.
[27] M. Hallett,et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.
[28] R. Koeppe,et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[29] J. Growdon,et al. Environment-driven responses in progressive supranuclear palsy , 1995, Journal of the Neurological Sciences.
[30] G. Seitz,et al. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression. , 1995, European journal of cancer.
[31] A. Lang,et al. Parkinsonism in alcohol withdrawal: A follow‐up study , 1990, Movement disorders : official journal of the Movement Disorder Society.